United Health Products Inc
For the period ended Jun 30, 2024. Filed Aug 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 13, 2024
UEECStored price and day change unavailable
Contents
Item 1. Financial Statements (Unaudited)Condensed Balance Sheets as of June 30, 2024 (unaudited) and December 31, 2023
UNITED HEALTH PRODUCTS, INC.
Condensed Balance Sheets
| June 30, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| (Unaudited) | ||
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $18,754 | $95,420 |
| Inventory | - | 33,598 |
| Prepaid and other current assets | 7,540 | 22,804 |
| Total current assets | 26,294 | 151,822 |
| Deferred offering costs | - | 21,051 |
| Operating lease right-of-use asset | 62,169 | 76,520 |
| Security deposit | 2,850 | 2,850 |
| Patents, net | 30,375 | 32,400 |
| TOTAL ASSETS | $121,688 | $284,643 |
| Current Liabilities | ||
| Accounts payable and accrued expenses | $1,027,618 | $987,567 |
| Accrued liabilities - related parties | 325,437 | 226,475 |
| Operating lease liability - current | 30,277 | 28,838 |
| Convertible notes payable, net of debt discount | 207,500 | 207,500 |
| Convertible notes payable – related party, net of debt discount | 500,000 | 500,000 |
| Total current liabilities | 2,090,832 | 1,950,380 |
| Operating lease liability – long-term | 33,277 | 48,489 |
| TOTAL LIABILITIES | 2,124,109 | 1,998,869 |
| Commitments and Contingencies | - | - |
| Stockholders’ Deficit | ||
| Series A Convertible Preferred Stock - $0.001 par value, 1,000,000 shares Authorized and 0 shares issued and outstanding | - | - |
| Common Stock - $0.001 par value, 300,000,000 shares Authorized, 248,233,222 and 244,783,222 shares issued and outstanding at June 30, 2024 and December 31, 2023 | 248,233 | 244,783 |
| Additional Paid-In Capital | 75,332,515 | 74,740,201 |
| Accumulated Deficit | (77,583,169) | (76,699,210) |
| Total Stockholders’ Deficit | (2,002,421) | (1,714,226) |
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $121,688 | $284,643 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.